Dr Penny Kechagioglou
Dr Penny Kechagioglou is a senior clinical oncology consultant with a diverse portfolio of clinical strategy, clinical governance, innovation and research. After qualifying as a doctor in Wales, she completed an internal medicine residency in UK, following which she completed and was awarded a CCT in Clinical Oncology (2010). Has worked as a consultant clinical oncologist in various UK NHS Trusts and has experience in managerial roles such as Chief Medical Officer at Genesis Care UK, Clinical Governance Lead for Oncology/Haematology in the NHS, Vice Chair and member of Research Ethics Committees, NICE Health Technology Assessment Committee member, Specialist advisor for the CQC and the Healthcare Ombudsman. Dr Kechagioglou is a principal investigator and co-investigator in many national and international breast cancer clinical trials and has a medical education portfolio as Senior Clinical Lecturer, Academic mentor, Medical tutor and postgraduate GP Educator. She has completed an MSc in Public Health and an MBA and she is currently working toward a Doctorate in Business Administration.
Breast cancer Service of the Future: a service transformation
The Breast Service of the Future is a service transformation project, which aims at combining all elements of excellent cancer care from diagnosis to survivorship. At times of financial and workforce pressures, there should not be any compromise in the quality, efficiency and access to world class cancer care. Cancer care should be patient-focused and individualised, from diagnosis through to surgery, radiotherapy, chemotherapy and surveillance. The presentation will take the audience the why and how this was achieved by a single private organization.
EVEN MORE SEMINARS
Dr. Henrik Harling 2cureX
IndiTreat® functional profiling, to match effective cancer drug treatment to individual cancer patients
Dr Abeer Shaaban Queen Elizabeth Hospital Birmingham & University of Birmingham
Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations
Lucinda Billingham University of Birmingham - Cancer Research Clinical Trials Unit
National Lung Matrix Trial: testing multiple novel targeted treatments
Dr Paul Fenton University Hospital Southampton NHS Foundation Trust
Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment (RAMPART) clinic
Islam Elkonaissi The Royal Marsden NHS Foundation Trust
The Multi-Specialty Challenge of Cancer Care